The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
作者： Jiyoung Rhee , Sae-Won Han , Do-Youn Oh , Jee Hyun Kim , Seock-Ah Im
关键词:
摘要: Background Triple-negative (TN) breast cancer, which is defined as being negative for the estrogen receptor (ER), progesterone (PR), and human epidermal growth factor 2 (HER-2), represents a subset of cancer with different biologic behaviour. We investigated clinicopathologic characteristics prognostic indicators lymph node-negative TN cancer.
biomedcentral.com
springer.com
paperity.org参考文章(36)
Su-ming Hsu, Laurence Raine, Herbert Fanger, A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. American Journal of Clinical Pathology. ,vol. 75, pp. 734- 738 ,(1981) , 10.1093/AJCP/75.5.734
Nicholas Turner, Andrew Tutt, Alan Ashworth, Hallmarks of 'BRCAness' in sporadic cancers Nature Reviews Cancer. ,vol. 4, pp. 814- 819 ,(2004) , 10.1038/NRC1457
Clinical characteristics of breast cancer patients in Korea in 2000. Archives of Surgery. ,vol. 139, pp. 27- 31 ,(2004) , 10.1001/ARCHSURG.139.1.27
A. de la Rochefordière, F. Campana, J. Fenton, J.R. Vilcoq, A. Fourquet, B. Asselain, S.M. Scholl, P. Pouillart, J.-C. Durand, H. Magdelenat, Age as prognostic factor in premenopausal breast carcinoma. The Lancet. ,vol. 341, pp. 1039- 1043 ,(1993) , 10.1016/0140-6736(93)92407-K
A J Nixon, D Neuberg, D F Hayes, R Gelman, J L Connolly, S Schnitt, A Abner, A Recht, F Vicini, J R Harris, Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. Journal of Clinical Oncology. ,vol. 12, pp. 888- 894 ,(1994) , 10.1200/JCO.1994.12.5.888
Hannah Farmer, Nuala McCabe, Christopher J. Lord, Andrew N. J. Tutt, Damian A. Johnson, Tobias B. Richardson, Manuela Santarosa, Krystyna J. Dillon, Ian Hickson, Charlotte Knights, Niall M. B. Martin, Stephen P. Jackson, Graeme C. M. Smith, Alan Ashworth, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature. ,vol. 434, pp. 917- 921 ,(2005) , 10.1038/NATURE03445
R.I. Nicholson, R.A. McClelland, P. Finlay, C.L. Eaton, W.J. Gullick, A.R. Dixon, J.F.R. Robertson, R.W. Blamey, I.O. Ellis, Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity European Journal of Cancer. ,vol. 29, pp. 1018- 1023 ,(1993) , 10.1016/S0959-8049(05)80215-1
Emad A. Rakha, Maysa E. El-Sayed, Andrew R. Green, Andrew H. S. Lee, John F. Robertson, Ian O. Ellis, Prognostic markers in triple-negative breast cancer Cancer. ,vol. 109, pp. 25- 32 ,(2007) , 10.1002/CNCR.22381
Katrina R. Bauer, Monica Brown, Rosemary D. Cress, Carol A. Parise, Vincent Caggiano, Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. ,vol. 109, pp. 1721- 1728 ,(2007) , 10.1002/CNCR.22618
Bhumsuk Keam, Seock-Ah Im, Hee-Jun Kim, Do-Youn Oh, Jee Hyun Kim, Se-Hoon Lee, Eui Kyu Chie, Wonshik Han, Dong-Wan Kim, Woo Kyung Moon, Tae-You Kim, In Ae Park, Dong-Young Noh, Dae Seog Heo, Sung Whan Ha, Yung-Jue Bang, None, Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer. BMC Cancer. ,vol. 7, pp. 203- 203 ,(2007) , 10.1186/1471-2407-7-203